PI3K-AKT pathway
Selected indexed studies
- PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression. (Pharmacol Res, 2024) [PMID:38992850]
- Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer. (Int J Mol Sci, 2023) [PMID:36901954]
- The PI3K/AKT/mTOR interactive pathway. (Mol Biosyst, 2015) [PMID:25924008]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer. (2023) pubmed
- The PI3K/AKT/mTOR interactive pathway. (2015) pubmed
- Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. (2022) pubmed
- PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression. (2024) pubmed
- PI3K/Akt/mTOR signaling pathway in cancer stem cells. (2022) pubmed
- Microneedle-Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K-Akt-mTOR Pathway. (2024) pubmed
- PI3k/AKT signaling pathway: Erythropoiesis and beyond. (2019) pubmed
- Adiponectin Attenuates Lipopolysaccharide-induced Apoptosis by Regulating the Cx43/PI3K/AKT Pathway. (2021) pubmed
- PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. (2022) pubmed
- PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. (2021) pubmed